ALEMBIC PHARMACEUTICALS
Back to Income Statement
|
ALEMBIC PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹7,345 Cr | ₹6,672 Cr | ₹6,229 Cr | ₹5,653 Cr | ₹5,306 Cr |
What is the latest Revenue of ALEMBIC PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹7,345 Cr |
| Mar2025 | ₹6,672 Cr |
| Mar2024 | ₹6,229 Cr |
| Mar2023 | ₹5,653 Cr |
| Mar2022 | ₹5,306 Cr |
How is Revenue of ALEMBIC PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,345 Cr | 10.08 | |
| Mar2025 | ₹6,672 Cr | 7.12 | |
| Mar2024 | ₹6,229 Cr | 10.19 | |
| Mar2023 | ₹5,653 Cr | 6.54 | |
| Mar2022 | ₹5,306 Cr | - | |
Compare Revenue of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹16,010.1 Cr | -2% | 0.1% | -13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -2% |
0.1% |
-13.4% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses